{"title":"作为前列腺癌生物标志物的微RNA：微型综述","authors":"Kowsalya R","doi":"10.18231/j.ijcbr.2023.049","DOIUrl":null,"url":null,"abstract":"Among men one of the most common cancers identified globally is prostate cancer. Although the serum prostate specific antigen remains important for prognosis and diagnosis, the PSA assay is not highly accurate. In the search for improved minimally invasive methods as a biomarker, the expression patterns of circulating miRNAs have a potential importance and are emerging as a promising candidate as prognostic markers for prostate cancer.","PeriodicalId":13899,"journal":{"name":"International Journal of Clinical Biochemistry and Research","volume":"78 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MicroRNAs as biomarkers in prostate cancer: A mini review\",\"authors\":\"Kowsalya R\",\"doi\":\"10.18231/j.ijcbr.2023.049\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Among men one of the most common cancers identified globally is prostate cancer. Although the serum prostate specific antigen remains important for prognosis and diagnosis, the PSA assay is not highly accurate. In the search for improved minimally invasive methods as a biomarker, the expression patterns of circulating miRNAs have a potential importance and are emerging as a promising candidate as prognostic markers for prostate cancer.\",\"PeriodicalId\":13899,\"journal\":{\"name\":\"International Journal of Clinical Biochemistry and Research\",\"volume\":\"78 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Biochemistry and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/j.ijcbr.2023.049\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Biochemistry and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.ijcbr.2023.049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
MicroRNAs as biomarkers in prostate cancer: A mini review
Among men one of the most common cancers identified globally is prostate cancer. Although the serum prostate specific antigen remains important for prognosis and diagnosis, the PSA assay is not highly accurate. In the search for improved minimally invasive methods as a biomarker, the expression patterns of circulating miRNAs have a potential importance and are emerging as a promising candidate as prognostic markers for prostate cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
